These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2547935)

  • 1. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release by U-50,488H of [3H]serotonin from brain slices and spinal cord synaptosomes of U-50,488H-tolerant and nontolerant mice.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1990 Jul; 254(1):8-12. PubMed ID: 2164102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioid analgesia is dependent on serotonergic mechanisms.
    Vonvoigtlander PF; Lewis RA; Neff GL
    J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
    Quock RM; Curtis BA; Reynolds BJ; Mueller JL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):117-22. PubMed ID: 8229738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
    Bhargava HN; Kumar S
    Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat.
    Gulati A; Ramarao P; Bhargava HN
    Pharmacology; 1989; 39(3):145-53. PubMed ID: 2587620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    J Pharmacol Exp Ther; 1994 Feb; 268(2):856-61. PubMed ID: 8113998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of serotonergic mechanisms in the inhibitory effect of U-50,488H on glutamate-induced lethality in mice.
    Kamei J; Igarashi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):357-60. PubMed ID: 1509202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Milanés MV; Laorden ML
    J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D; Pick CG; Tive LA; Pasternak GW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.